Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Panciu, Traian Constantin; Masgras, Bianca; Ciuca, Catrinel; Ciomag, Raluca; Mihăilescu, Anca; Gurghean, Adriana

Open Access

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Panciu, Traian Constantin

,

,

,

,

and

Jul 20, 2018

Volume 15 (2018): Issue 3 (July 2018)

About this article

Cite

Share

Download Cover

Published Online: Jul 20, 2018

Page range: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Keywords
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Panciu, Traian Constantin

Clinical Hospital Colţea Bucharest

Masgras, Bianca

Clinical Hospital Colţea Bucharest

Ciuca, Catrinel

Clinical Hospital Colţea Bucharest

Ciomag, Raluca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Mihăilescu, Anca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Gurghean, Adriana

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Language:: English

Publication timeframe:: 4 times per year
Journal Subjects:: Medicine, Clinical Medicine, Internal Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Pneumology

Journal RSS Feed

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Bianca Masgras

Catrinel Ciuca

Raluca Ciomag

Anca Mihăilescu

Adriana Gurghean

Published Online: Jul 20, 2018

Page range: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

KeywordsErlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Keywords
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome